Evidence map›Paper›PMID 25265186›Full record

Observational studyPloS one2014

Effectiveness of pandemic and seasonal influenza vaccines in preventing laboratory-confirmed influenza in adults: a clinical cohort study during epidemic seasons 2009-2010 and 2010-2011 in Finland.

Ritva K Syrjänen, Jukka Jokinen, Thedi Ziegler, Jonas Sundman, Mika Lahdenkari, Ilkka Julkunen, Terhi M Kilpi

2 registry-linked trialsAbstract readObservational Study
In one paragraph

Observational study in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01024725 completednot on this map

Evaluation of a Vaccination Campaign With A(H1N1)v Pandemic Vaccines: a Prospective Cohort Study

TypeobservationalSponsorFinnish Institute for Health and WelfareRan2009 to 2014Enrolled3,518ConditionsInfluenza Caused by the Novel A(H1N1)v Influenza VirusArmsFollow-up
NCT01206114 completednot on this map

Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11

TypeobservationalSponsorFinnish Institute for Health and WelfareRan2010 to 2014Enrolled2,351ConditionsInfluenza Caused by the 2009 H1N1 Influenza VirusArmsFollow-up
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Article
  9. Effects of Prior Season Vaccination on Current Season Vaccine Effectiveness in the United States Flu Vaccine Effectiveness Network, 2012-2013 Through 2017-2018.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ritva K SyrjänenDepartment of Vaccination and Immune Protection, National Institute for Health and Welfare, Tampere, Finland.
Jukka JokinenDepartment of Vaccination and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland.
Thedi ZieglerDepartment of Vaccination and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland.
Jonas SundmanDepartment of Vaccination and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland.
Mika LahdenkariDepartment of Vaccination and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland.
Ilkka JulkunenDepartment of Vaccination and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland.
Terhi M KilpiDepartment of Vaccination and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOne dose of pandemic influenza vaccine Pandemrix (GlaxoSmithKline) was offered to the entire population of Finland in 2009-10. We conducted a prospective clinical cohort study to determine the vaccine effectiveness in preventing febrile laboratory-confirmed influenza infection during the influenza season 2009-10 and continued the study in 2010-11.

methodsIn total, 3,518 community dwelling adults aged 18-75 years living in Tampere city were enrolled. The participants were not assigned to any vaccination regimen, but they could participate in the study regardless of their vaccination status or intention to be vaccinated with the pandemic or seasonal influenza vaccine. They were asked to report if they received Pandemrix in 2009-10 and/or trivalent influenza vaccine in 2010-11. Vaccinations were verified from medical records. The participants were instructed to report all acute symptoms of respiratory tract infection with fever (at least 38°C) and pneumonias to the study staff. Nasal and oral swabs were obtained within 5-7 days after symptom onset and influenza-specific RNA was identified by reverse transcription polymerase chain reaction.

resultsIn 2009-10, the estimated vaccine effectiveness was 81% (95%CI 30-97). However, the vaccine effectiveness could not be estimated reliably, because only persons in prioritized groups were vaccinated before/during the first pandemic wave and many participants were enrolled when they already had the symptoms of A(H1N1)pdm09 influenza infection. In 2010-11, 2,276 participants continued the follow-up. The vaccine effectiveness, adjusted for potential confounding factors was 81% (95%CI 41-96) for Pandemrix only and 88% (95%CI 63-97) for either Pandemrix or trivalent influenza vaccine 2010-11 or both, respectively.

conclusionVaccination with an AS03-adjuvanted pandemic vaccine in 2009-10 was still effective in preventing A(H1N1)pdm09 influenza during the following epidemic season in 2010-11.

trial registrationClinicalTrials.gov NCT01024725. NCT01206114.

Indexed as

AdolescentAdultAgedCohort StudiesFemaleFinlandHumansInfluenza A Virus, H1N1 SubtypeInfluenza, HumanInfluenza VaccinesMaleMiddle AgedProspective StudiesVaccinationYoung AdultInfluenza Vaccinespandemrix

Identifiers

PMID25265186
PMCPMC4180439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.